Fecal Calprotectin and Cow’s MilkRelated-Symptoms Score in Children with Cow’s Milk Protein Allergy
10.5223/pghn.2023.26.1.43
- Author:
Sahar ZAIN-ALABEDEEN
1
;
Noha KAMEL
;
Mona AMIN
;
Angharad VERNON-ROBERTS
;
Andrew S DAY
;
Abdelmoneim KHASHANA
Author Information
1. Department of Pediatrics, Bilbeis Central Hospital, Zagazig, Egypt
- Publication Type:Original Article
- From:Pediatric Gastroenterology, Hepatology & Nutrition
2023;26(1):43-49
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:The cow’s milk-related-symptom-score (CoMiSS) tool was developed as an awareness tool for the assessment of cow’s milk-related symptoms in infants or children.Fecal calprotectin (FC) is a noninvasive biomarker of gut inflammation that can be measured in serum and stool. This study aimed to investigate the relationship between FC levels and CoMiSS scores in infants with cow’s milk protein allergy.
Methods:Infants (aged 6–12 months) who were allergic to cow’s milk protein were enrolled prospectively. Following completion of the CoMiSS scoring, the infants were divided into group 1 (positive CoMiSS scores ≥12) and group 2 (negative CoMiSS scores <12). FC was measured using immunoassay.
Results:Of the 120 infants enrolled in this study, 60 (50.0%) had positive CoMiSS scores (group 1), while 60 (50.0%) had negative scores (group 2). The mean FC level was higher in the infants in group 1 than those in group 2 (2,934.57 µg/g vs. 955.13 µg/g; p<0.001). In addition, there was a positive correlation between FC and CoMiSS scores (R=0.168, p<0.0001). A FC level of 1,700 µg/g provided a sensitivity of 98.3%, specificity of 93.3%, and accuracy of 95.8% for the diagnosis of cow’s milk protein allergy (CMPA).
Conclusion:FC measurement may have a role in the assessing infants with CMPA.
